1. Home
  2. AXTI vs BBNX Comparison

AXTI vs BBNX Comparison

Compare AXTI & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$17.92

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.79

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
BBNX
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1998
2025

Fundamental Metrics

Financial Performance
Metric
AXTI
BBNX
Price
$17.92
$16.79
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
$11.05
$29.75
AVG Volume (30 Days)
7.4M
1.4M
Earning Date
02-19-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,390,000.00
$88,570,000.00
Revenue This Year
N/A
$53.22
Revenue Next Year
$33.52
$35.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.01
52 Week Low
$1.13
$8.89
52 Week High
$26.66
$32.71

Technical Indicators

Market Signals
Indicator
AXTI
BBNX
Relative Strength Index (RSI) 48.35 27.17
Support Level $20.00 $16.02
Resistance Level $26.66 $19.03
Average True Range (ATR) 3.20 1.92
MACD -0.52 -1.06
Stochastic Oscillator 27.57 4.38

Price Performance

Historical Comparison
AXTI
BBNX

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: